William A. Haseltine, chairman and chief executive officer of Human Genome Sciences, Inc. (Rockville, MD; 301-309-8504) said the company agrees with President Clinton's reported opposition to broad patents covering the human genetic code as well as his reported support for patenting "specific discoveries and developments that have a clear and definable benefit."
"The President is dead right in opposing broad patents of the human genetic code. That would be an abuse of the patent process -- locking up commercial rights without placing correspondingly valuable knowledge in the public domain. The beauty of patents is their implicit quid pro quo," he added. "To get a …
Комментариев нет:
Отправить комментарий